WHO warns against using non-sugar sweeteners for weight control
WHO advises against using non-sugar sweeteners to manage body weight or lower the risk of noncommunicable diseases.
Archives: News
Read More
The new WHO report highlights progress and unmet needs for a strong pipeline of antibiotic combating antimicrobial resistance
Although the R&D pipeline for new antibiotics is small and access to both new and existing therapies remains difficult, antimicrobial resistance was linked to approximately 5 million fatalities in 2019.
Positive Phase 3 Results for TREMFYA® (Guselkumab) in Ulcerative Colitis Patients
Janssen released new efficacy and safety data on TREMFYA® for treating moderately to severely active ulcerative colitis in adults
Thermo and Pfizer partner to offer localized Next-Generation Sequencing (NGS)-based testing for cancer patients worldwide
Thermo Fisher Scientific and Pfizer partner to offer localized next-generation sequencing (NGS)-based testing for cancer patients worldwide
Lupin Limited Released its Financial Results for the Quarter and Fiscal Year Ending March 31, 2023
Lupin Limited, a leading pharmaceutical company, released its financial results for the quarter and fiscal year ending March 31, 2023
Fifth Meeting of the Multi-Country Monkeypox Outbreak Emergency Committee (2005) held
The Emergency Committee recognized that the worldwide response to the multi-country monkeypox outbreak has improved
After labor, a life-saving treatment E-MOTIVE significantly lessens serious bleeding
According to researchers from WHO and the University of Birmingham, a groundbreaking study released today shows that E-MOTIVE, a novel approach, may greatly reduce mortality from childbirth-related bleeding. Postpartum hemorrhage (PPH) is the biggest cause of maternal death globally, defined as the loss of more than 500 mL of blood within 24 hours of giving…
Since 2015, the World has made Little Progress in Reducing Maternal and Neonatal Fatalities: United Nations
According to a recent United Nations (UN) report, progress in lowering maternal and maternal and neonatal fatalities worldwide has stagnated for eight years as a result of diminishing investments in these areas.
Medisol, a French Pharmaceutical Company, has been Acquired by Lupin
The French Ministry of Economy and Finance will need to approve Lupin Limited’s (Lupin) formal agreement before it can purchase Medisol complete share capital.
The U.S. introduction of Regadenoson Injection 0.4 mg/5 mL is announced by Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories Ltd. and its subsidiaries announced the release of Regadenoson injectable, a generic pharmaceutical substitute for Lexiscan® (Regadenoson) injectable that has been given US Food and Drug Administration (USFDA) approval, on the American market.
